IRadimed Corporation (IRMD)
USD 51.36
(-4.18%)
USD 51.36
(-4.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 20.8 Million USD | 33.1% |
| 2022 | 16.29 Million USD | 39.23% |
| 2021 | 11.22 Million USD | 1826.18% |
| 2020 | 582.73 Thousand USD | -94.11% |
| 2019 | 9.88 Million USD | 39.12% |
| 2018 | 7.1 Million USD | 174.07% |
| 2017 | 2.59 Million USD | -76.78% |
| 2016 | 11.16 Million USD | -4.85% |
| 2015 | 11.51 Million USD | 265.08% |
| 2014 | 3.21 Million USD | 9.87% |
| 2013 | 2.92 Million USD | 91.14% |
| 2012 | 1.53 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 5.82 Million USD | 2.88% |
| 2024 Q1 | 4.97 Million USD | -7.09% |
| 2024 Q3 | 5.78 Million USD | 2.88% |
| 2023 Q2 | 5.15 Million USD | 22.93% |
| 2023 FY | - USD | 33.1% |
| 2023 Q1 | 4.18 Million USD | -1.51% |
| 2023 Q4 | 5.15 Million USD | -12.62% |
| 2023 Q3 | 5.9 Million USD | 14.66% |
| 2022 Q2 | 4.66 Million USD | 32.83% |
| 2022 Q1 | 3.5 Million USD | 0.36% |
| 2022 FY | - USD | 39.23% |
| 2022 Q4 | 4.25 Million USD | -6.87% |
| 2022 Q3 | 4.56 Million USD | -2.0% |
| 2021 Q1 | 2.1 Million USD | 113.0% |
| 2021 Q2 | 2.19 Million USD | 3.97% |
| 2021 FY | - USD | 1826.18% |
| 2021 Q3 | 3.42 Million USD | 56.3% |
| 2021 Q4 | 3.49 Million USD | 2.02% |
| 2020 Q3 | 1.11 Million USD | 142.83% |
| 2020 Q4 | 990.03 Thousand USD | -11.27% |
| 2020 FY | - USD | -94.11% |
| 2020 Q1 | 1.08 Million USD | -57.06% |
| 2020 Q2 | -2.6 Million USD | -340.76% |
| 2019 FY | - USD | 39.12% |
| 2019 Q1 | 1.9 Million USD | -7.41% |
| 2019 Q4 | 2.51 Million USD | -10.26% |
| 2019 Q3 | 2.8 Million USD | 5.5% |
| 2019 Q2 | 2.66 Million USD | 40.01% |
| 2018 Q4 | 2.05 Million USD | 40.34% |
| 2018 Q2 | 2.07 Million USD | 37.15% |
| 2018 Q1 | 1.51 Million USD | 13.25% |
| 2018 FY | - USD | 174.07% |
| 2018 Q3 | 1.46 Million USD | -29.6% |
| 2017 Q2 | 442.52 Thousand USD | 386.78% |
| 2017 Q4 | 1.33 Million USD | 38.24% |
| 2017 FY | - USD | -76.78% |
| 2017 Q1 | -154.31 Thousand USD | -109.83% |
| 2017 Q3 | 967.74 Thousand USD | 118.68% |
| 2016 Q1 | 3.54 Million USD | 3.81% |
| 2016 FY | - USD | -4.85% |
| 2016 Q4 | 1.56 Million USD | -40.9% |
| 2016 Q3 | 2.65 Million USD | -21.95% |
| 2016 Q2 | 3.4 Million USD | -3.96% |
| 2015 Q3 | 3.26 Million USD | 18.61% |
| 2015 Q2 | 2.74 Million USD | 18.69% |
| 2015 Q1 | 2.31 Million USD | 742.74% |
| 2015 FY | - USD | 265.08% |
| 2015 Q4 | 3.41 Million USD | 4.66% |
| 2014 FY | - USD | 9.87% |
| 2014 Q4 | 274.79 Thousand USD | -39.14% |
| 2014 Q1 | 844.85 Thousand USD | 10.59% |
| 2014 Q2 | 1.61 Million USD | 90.58% |
| 2014 Q3 | 451.48 Thousand USD | -71.96% |
| 2013 FY | - USD | 91.14% |
| 2013 Q2 | 812.89 Thousand USD | -15.4% |
| 2013 Q4 | 763.94 Thousand USD | 96.59% |
| 2013 Q3 | 388.59 Thousand USD | -52.2% |
| 2013 Q1 | 960.82 Thousand USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 254.227% |
| Cerus Corporation | -26.53 Million USD | 178.386% |
| OrthoPediatrics Corp. | -8.38 Million USD | 348.188% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 298.205% |
| Talis Biomedical Corporation | -66.04 Million USD | 131.495% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 224.741% |
| Inogen, Inc. | -45.67 Million USD | 145.537% |
| Spectral AI, Inc. | -12.26 Million USD | 269.635% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 143.614% |
| CVRx, Inc. | -38.73 Million USD | 153.705% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 689.587% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 271.807% |
| Orthofix Medical Inc. | -86.98 Million USD | 123.913% |
| Venus Concept Inc. | -26.11 Million USD | 179.656% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 141.793% |
| Bioventus Inc. | -23.07 Million USD | 190.163% |
| BrainsWay Ltd. | -2.31 Million USD | 1000.071% |
| Envoy Medical, Inc. | -18.23 Million USD | 214.051% |
| electroCore, Inc. | -17.76 Million USD | 217.121% |
| IceCure Medical Ltd | -15.25 Million USD | 236.371% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 141.809% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 223.404% |
| MaxCyte, Inc. | -44.12 Million USD | 147.137% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 276.937% |
| Nexalin Technology, Inc. | -5.69 Million USD | 465.434% |
| PAVmed Inc | -75.74 Million USD | 127.462% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 138.693% |
| RxSight, Inc. | -41.03 Million USD | 150.688% |
| Sight Sciences, Inc. | -49.41 Million USD | 142.094% |
| SI-BONE, Inc. | -34.44 Million USD | 160.386% |
| TELA Bio, Inc. | -40.63 Million USD | 151.191% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 135.68% |
| Treace Medical Concepts, Inc. | -39 Million USD | 153.324% |
| LivaNova PLC | 39.01 Million USD | 46.687% |
| 908 Devices Inc. | -34.02 Million USD | 161.133% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 118.808% |
| Nemaura Medical Inc. | -7.28 Million USD | 385.446% |
| NeuroPace, Inc. | -22.83 Million USD | 191.095% |
| LENSAR, Inc. | -8.71 Million USD | 338.704% |
| Apyx Medical Corporation | -18.11 Million USD | 214.845% |
| Cutera, Inc. | -136.56 Million USD | 115.232% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 715.403% |
| BioSig Technologies, Inc. | -28.15 Million USD | 173.89% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -726.734% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 199.103% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 94.577% |
| Axonics, Inc. | 7.77 Million USD | -167.532% |
| Outset Medical, Inc. | -153.78 Million USD | 113.525% |
| IRIDEX Corporation | -7.44 Million USD | 379.278% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 121.205% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 358.008% |
| INVO Bioscience, Inc. | -6.88 Million USD | 402.334% |
| Telesis Bio, Inc. | -40.49 Million USD | 151.368% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 43.287% |
| Varex Imaging Corporation | 67.2 Million USD | 69.047% |
| Quipt Home Medical Corp. | 44.07 Million USD | 52.802% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 291.358% |
| Pulmonx Corporation | -55.09 Million USD | 137.756% |
| Dynatronics Corporation | -976 Thousand USD | 2231.195% |
| Modular Medical, Inc. | -17.1 Million USD | 221.62% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 243.601% |
| Semler Scientific, Inc. | 23.58 Million USD | 11.821% |
| InMode Ltd. | 196.28 Million USD | 89.403% |
| Bruker Corporation | 599 Million USD | 96.527% |
| Cytosorbents Corporation | -28.81 Million USD | 172.197% |
| DexCom, Inc. | 916.7 Million USD | 97.731% |
| Align Technology, Inc. | 799.03 Million USD | 97.397% |
| Viveve Medical, Inc. | -20.61 Million USD | 200.891% |
| ZimVie Inc. | 91.07 Million USD | 77.16% |
| Movano Inc. | -29.12 Million USD | 171.418% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 571.884% |
| Nexalin Technology, Inc. | -5.69 Million USD | 465.434% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 689.587% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 110.686% |
| Profound Medical Corp. | -27.12 Million USD | 176.689% |
| Insulet Corporation | 323.6 Million USD | 93.572% |
| enVVeno Medical Corporation | -25.01 Million USD | 183.143% |
| Surmodics, Inc. | 1.18 Million USD | -1650.895% |
| iCAD, Inc. | -6.56 Million USD | 416.841% |
| Nuwellis, Inc. | -16.35 Million USD | 227.174% |
| Biotricity, Inc. | -8.82 Million USD | 335.614% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 121.475% |
| Aethlon Medical, Inc. | -11.84 Million USD | 275.546% |
| InspireMD, Inc. | -20.91 Million USD | 199.472% |
| PAVmed Inc. | -75.74 Million USD | 127.462% |
| BIOLASE, Inc. | -15.13 Million USD | 237.398% |
| Beyond Air, Inc. | -59.03 Million USD | 135.237% |
| FONAR Corporation | 28.25 Million USD | 26.374% |
| AxoGen, Inc. | -13.32 Million USD | 256.067% |
| Vivani Medical, Inc. | -26.6 Million USD | 178.174% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 15.241% |
| Inari Medical, Inc. | 7.11 Million USD | -192.431% |
| UFP Technologies, Inc. | 72.74 Million USD | 71.405% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 714.352% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 437.892% |
| Tenon Medical, Inc. | -15.52 Million USD | 233.956% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 236.255% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 150.151% |
| AdaptHealth Corp. | -171.09 Million USD | 112.158% |
| Sintx Technologies, Inc. | -6.6 Million USD | 415.161% |
| NanoVibronix, Inc. | -3.43 Million USD | 705.55% |
| Quanterix Corporation | -38.08 Million USD | 154.612% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 291.358% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -69235.46% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 107.502% |
| TransMedics Group, Inc. | -7.6 Million USD | 373.585% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 195.569% |
| NeuroMetrix, Inc. | -7.09 Million USD | 393.14% |
| Hyperfine, Inc. | -47.06 Million USD | 144.199% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 135.674% |
| Biomerica, Inc. | -5.99 Million USD | 447.082% |
| Bone Biologics Corporation | 479.57 Thousand USD | -4237.334% |
| AVITA Medical, Inc. | -39.56 Million USD | 152.57% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 326.761% |
| Silk Road Medical, Inc | -45.08 Million USD | 146.142% |